Neil Klompas

Mr. Neil A. Klompas, CPA, is a President & Chief Executive Officer at Augurex Life Sciences Corp., an Independent Non-Executive Director at NervGen Pharma Corp.
and a Member at The Chartered Professional Accountants of British Columbia.
He is on the Board of Directors at InMed Pharmaceuticals, Inc., NervGen Pharma Corp., Canadian Gene Cure Foundation and HTuO Biosciences, Inc. Mr. Klompas was previously employed as an Independent Director by Liminal BioSciences, Inc., a Chief Operating Officer by Zymeworks BC, Inc., a President & Chief Operating Officer by Zymeworks, Inc., a Manager-Mergers & Acquisitions Transactions by KPMG LLP, and an Audit Manager by KPMG LLP (Canada).
He also served on the board at Ovensa, Inc. He received his undergraduate degree from the University of British Columbia.